Feedback
Settings

Settings

Goto Application

1. WO2017189892 - METHODS, SYSTEM, AND KIT FOR MONITORING, DIAGNOSING, AND TREATING IMPULSIVE AGGRESSION

PermaLink
Publication Number WO/2017/189892
Publication Date 02.11.2017
International Application No. PCT/US2017/029919
International Filing Date 27.04.2017
IPC
G06F 19/00 2011.01
GPHYSICS
06COMPUTING; CALCULATING OR COUNTING
FELECTRIC DIGITAL DATA PROCESSING
19Digital computing or data processing equipment or methods, specially adapted for specific applications
CPC
A61K 31/5377
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
535having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
53751,4-Oxazines, e.g. morpholine
5377not condensed and containing further heterocyclic rings, e.g. timolol
A61P 25/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
14for treating abnormal movements, e.g. chorea, dyskinesia
A61P 25/18
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
A61P 25/20
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
20Hypnotics; Sedatives
G16H 10/20
GPHYSICS
16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
10ICT specially adapted for the handling or processing of patient-related medical or healthcare data
20for electronic clinical trials or questionnaires
G16H 50/20
GPHYSICS
16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
50ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
20for computer-aided diagnosis, e.g. based on medical expert systems
Applicants
  • SUPERNUS PHARMACEUTICALS, INC. [US]/[US]
Inventors
  • DUGAN STOCKS, Jennifer
  • EVANS, Christopher
  • HWANG, Seung
  • DALLABRIDA, Susan M.
Agents
  • TALAPATRA, Sunit
  • NADIPURAM, Asha
  • MAEBIUS, Stephen B.
  • LAW, Glenn
  • BRINCKERHOFF, Courtenay
  • SCHORR, Kristel
  • BECK, George C.
  • BERKOWITZ, Benjamin A.
  • SIMKIN, Michele M.
  • VILLACORTA, Gilberto M.
Priority Data
62/329,68829.04.2016US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) METHODS, SYSTEM, AND KIT FOR MONITORING, DIAGNOSING, AND TREATING IMPULSIVE AGGRESSION
(FR) PROCÉDÉS, SYSTÈME ET KIT DE SURVEILLANCE, DE DIAGNOSTIC ET DE TRAITEMENT D’UNE AGRESSION IMPULSIVE
front page image
Abstract
(EN)
The present disclosure relates to the treatment of impulsive aggression with molindone as an add-on therapy where patients are already receiving treatment for the underlying disease or disorder, e.g. attention deficit hyperactivity disorder (ADHD), bipolar disorder, autism, Tourette's syndrome or post traumatic stress disorder (PTSD), using evidence-based impulsive aggression testing methodologies and systems.
(FR)
La présente invention concerne le traitement d’une agression impulsive avec du molindone en tant que thérapie supplémentaire au cours de laquelle des patients reçoivent déjà un traitement pour la maladie ou le trouble sous-jacent, par exemple le trouble d’hyperactivité avec déficit de l’attention (THADA), le trouble bipolaire, l'autisme, le syndrome de Tourette ou le trouble de stress post-traumatique (PTSD), à l’aide de méthodes et de systèmes de test d’agression impulsive basés sur des preuves.
Also published as
AU2017258303
EP3449402
JP2019520315
CA3022339
MXMX/a/2018/013113
Latest bibliographic data on file with the International Bureau
# -